Within 48 hours of Moderna's vaccine announcement, its execs sold $29 million in shares.
The stock market is euphoric over news of a possible coronavirus vaccine. But for now, you shouldn’t be.Was the timing coincidental? Moderna didn’t reply to my question about that. But it’s something the Securities and Exchange Commission should be examining, because if it wasn’t a coincidence, then that would imply that the company manipulated the stock market for its executives’ benefit.
“The optics of this aren’t great,” says Charles Elson, a corporate governance expert at the University of Delaware.Elson is wary of any stock sales by executives during their tenures. “Traditionally, when you leave a company,you sell,” he told me. “If you sell while you’re there, that doesn’t show a lot of confidence in what you’re doing.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Dow Surges 600 Points As Investors Bet On A Coronavirus Vaccine BreakthroughStocks are racing higher on hopes for a new coronavirus vaccine.
Lire la suite »
Asia Pacific stocks set to trade higher on vaccine hopes; Japan lifts state of emergencyAmerican biotech firm Novavax said Monday it started the first human study of its experimental coronavirus vaccine.
Lire la suite »
Global stock markets rally as coronavirus vaccine hopes come into focusStock markets around the world surged on Tuesday as hopes for a coronavirus vaccine and the easing of lockdown restrictions worldwide drive investors back toward risk assets.
Lire la suite »
He experienced a severe reaction to Moderna's Covid-19 vaccine candidate. He's still a believerAs the experimental Covid-19 vaccine being developed by Moderna Therapeutics has begun advancing through studies, it has found an advocate: trial volunteer Ian Haydon, a 29-year-old in Seattle, STAT News reports.
Lire la suite »
Novavax begins human trials with potential Covid-19 vaccine in AustraliaNovavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and looking for signs of its effectiveness.
Lire la suite »